ASX:COHCochlear Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$190.98 +2.31 (+1.22 %) (As of 05/13/2020) Add Compare Share Today's RangeA$184.18Now: A$190.98▼A$190.9850-Day RangeA$190.98MA: A$190.98▼A$190.9852-Week RangeA$154.60Now: A$190.98▼A$254.40Volume201,277 shsAverage Volume194,422 shsMarket Capitalization$12.54 billionP/E Ratio36.07Dividend Yield1.94%BetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsInsider TradesHeadlinesOptions Chain Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses. The company has strategic collaborations with Sensorion and GN Hearing A/S to focus on improving hearing outcomes in patients with cochlear implants. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Cochlear. Previous Next 2.0 Community Rank Outperform VotesCochlear has received 164 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCochlear has received 250 “underperform” votes. (Add your “underperform” vote.)Community SentimentCochlear has received 60.39% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cochlear and other stocks. Vote “Outperform” if you believe COH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe COH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend YieldCochlear pays a meaningful dividend of 1.94%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthCochlear does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Cochlear is 63.28%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cochlear insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$29,960.00 in company stock and sold A$0.00 in company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Cochlear are expected to decrease by -100.00% in the coming year, from A$5.03 to A$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cochlear is 36.07, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.68.Price to Earnings Ratio vs. SectorThe P/E ratio of Cochlear is 36.07, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.34.Price to Book Value per Share RatioCochlear has a P/B Ratio of 13.69. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.33 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolASX:COH Previous Symbol CUSIPN/A CIKN/A Webwww.cochlear.com Phone+61-2-94286555Debt Debt-to-Equity Ratio52.41 Current Ratio1.87 Quick Ratio1.18Price-To-Earnings Trailing P/E Ratio36.07 Forward P/E Ratio37.99 P/E GrowthN/A Sales & Book Value Annual Sales$1.48 billion Price / Sales8.48 Cash FlowA$1.55 per share Price / Cash Flow123.45 Book ValueA$13.95 per share Price / Book13.69Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees3,500 Outstanding Shares65,687,400Market Cap$12.54 billion Next Earnings Date8/19/2020 (Estimated) OptionableOptionable Receive COH News and Ratings via Email Sign-up to receive the latest news and ratings for COH and its competitors with MarketBeat's FREE daily newsletter. Cochlear (ASX:COH) Frequently Asked Questions How has Cochlear's stock been impacted by COVID-19 (Coronavirus)? Cochlear's stock was trading at A$189.02 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, COH shares have increased by 1.0% and is now trading at A$190.98. View which stocks have been most impacted by Coronavirus. When is Cochlear's next earnings date? Cochlear is scheduled to release its next quarterly earnings announcement on Wednesday, August 19th 2020. View our earnings forecast for Cochlear. How were Cochlear's earnings last quarter? Cochlear Limited (ASX:COH) issued its quarterly earnings data on Tuesday, February, 19th. The company reported $2.15 EPS for the quarter, missing the Zacks' consensus estimate of $2.19 by $0.04. View Cochlear's earnings history. How often does Cochlear pay dividends? What is the dividend yield for Cochlear? Cochlear announced a Interim dividend on Wednesday, February 19th. Stockholders of record on Friday, April 17th will be paid a dividend of 1.60 per share on Friday, April 17th. This represents a dividend yield of 0.64%. The ex-dividend date of this dividend is Tuesday, March 24th. This is an increase from Cochlear's previous Interim dividend of A$1.55. View Cochlear's dividend history. Has Cochlear been receiving favorable news coverage? News coverage about COH stock has been trending negative recently, according to InfoTrie. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cochlear earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about Cochlear. Who are some of Cochlear's key competitors? Some companies that are related to Cochlear include Fisher & Paykel Healthcare (FPH), ConvaTec Group (CTEC), Avita Medical (AVH), Stratec (SBS), Zynex (ZYXI), Draegerwerk AG & Co KGaA (DRW3), Creo Medical Group (CREO), Avacta Group (AVCT), Hamilton Thorne (HTL), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), Medica Group (MGP), Electromed (ELMD), Electromed (ELMD), Cyclopharm (CYC) and Patient Home Monitoring (PTQ). View all competitors. What other stocks do shareholders of Cochlear own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares S&P 500 ETF (IVV), CSL (CSL), ResMed (RMD), Rio Tinto (RIO), Altium (ALU), Abbott Laboratories (ABT), Afterpay Touch Group (APT), Appen (APX), Alumina (AWC) and Cross Timbers Royalty Trust (CRT). Who are Cochlear's key executives? Cochlear's management team includes the following people: Mr. Diggory William Howitt, CEO, MD, Pres & Exec. Director (Age 52)Mr. Brent Andrew Cubis, Chief Financial OfficerMr. Jan Janssen, Chief Technology OfficerMr. Richard Brook, Pres of EMEA & Latin American RegionMr. Anthony Manna, Pres of Americas Region What is Cochlear's stock symbol? Cochlear trades on the ASX under the ticker symbol "COH." What is Cochlear's stock price today? One share of COH stock can currently be purchased for approximately A$190.98. How big of a company is Cochlear? Cochlear has a market capitalization of $12.54 billion and generates $1.48 billion in revenue each year. Cochlear employs 3,500 workers across the globe. What is Cochlear's official website? The official website for Cochlear is www.cochlear.com. How can I contact Cochlear? Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company can be reached via phone at +61-2-94286555. This page was last updated on 7/6/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
